What Archimedes Capital does

Archimedes Capital is a privately held venture capital, private equity, and alternative asset investment firm organized as Archimedes Capital, LLC. Incorporated in the United States and headquartered at 6500 River Place Boulevard, Building 7, Suite 250, in Austin, Texas, the firm invests across the full company lifecycle, from seed-stage ventures through pre-IPO and later-stage opportunities, with a stated emphasis on deals that benefit from the principals' operational expertise and discreet networks. The firm's principals are described as technology and operations executives, all US-born, US-resident, US citizens, who have collectively built and advised companies for more than three decades and led the investment of multiple billions of dollars since 1993, with significant cash-on-cash returns and billions of dollars of portfolio enterprise value created.

The firm's core products are its three investment offerings: venture capital for early-stage companies, private equity for established pre-IPO and later-stage companies, and alternative asset deals in arenas requiring high discretion and trust, including sectors adjacent to US and allied government and policy leaders. The platform is built around principal-level talent and relationship capital rather than institutional scale, and the firm's public positioning emphasizes reduced risk and improved returns through the combination of operational skills, strategic connections, and investment judgment. Matthew Ocko is identified as a Managing Director, and the firm is led by a small principal group rather than a large management hierarchy.

Archimedes Capital generates revenue through the standard alternative asset manager model: management fees on capital under management and carried interest on successful portfolio exits, with no productized or subscription-based offerings. The firm does not publicly disclose pricing, fund sizes, AUM, or deal terms, and engagement with portfolio companies and limited partners is negotiated individually. The customer base consists of portfolio companies receiving capital and limited partners committing capital, with no public logos or case studies disclosed.

Name

Archimedes Capital

Legal name

Archimedes Capital, LLC

Website

https://archcap.com

Company type

Private

Founded year

1993

Operating status

Operating

Short description

Archimedes Capital is a private US venture capital, private equity, and alternative asset investment firm that deploys capital from seed through pre-IPO into deals benefiting from its principals' decades of technology, operations, and trusted US-and-allied-network relationships.

Ownership category

akta.pro rank

Product category

Private Equity / Venture Capital

NAICS

Other Investment Pools and Funds (5259)

akta.pro primary industry

Large-Cap / Mega-Fund Buyout (FSANABAA)

Keywords

• Venture capital investing
• Private equity investing
• Alternative asset management
• Seed stage funding
• Pre-IPO investment

Headquarters

HQ city

Palo Alto

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations

Revenue model

1. Investment Returns and Fund Management: As a venture capital and private equity firm, Archimedes Capital generates revenue through returns on investments in portfolio companies, management fees on funds under management, and carried interest from successful exits. The firm deploys capital across seed, venture, pre-IPO, and later-stage alternative asset opportunities.

Core offering

Archimedes Capital is a venture capital, private equity, and alternative asset investment firm that deploys capital across the full investment lifecycle—from seed-stage startups through pre-IPO and later-stage companies. The firm invests in opportunities where its principals' decades of technology and operations experience, paired with trusted US and allied leader networks, can accelerate success and reduce risk.

Product overview

Archimedes Capital operates as a unified investment platform offering venture capital, private equity, and alternative asset investment services. The firm deploys capital across the full investment lifecycle—from seed-stage startups through pre-IPO and later-stage companies—focusing on opportunities where its principals' decades of technology and operations expertise, along with their strategic connections, can accelerate success and reduce risk. The three investment products work together under the Archimedes Capital brand, with principals leveraging their operational experience to add value across all portfolio companies.

Differentiator

Problem solved

Functional benefit

Products and services

• Venture Capital Investment Venture capital investment in early-stage companies from seed funding onward, providing capital and strategic guidance to emerging technology ventures with potential for high growth and market disruption.
• Private Equity Investment Private equity investment in established companies at pre-IPO or later stages, focusing on opportunities that can leverage Archimedes' principals' operational expertise and strategic connections.
• Alternative Asset Investments Alternative asset investment opportunities across diverse sectors, including arenas requiring high security and trust standards for US and allied leaders.

Quantifiable outcome

• Multiple billions of dollars invested since 1993 with significant multiple cash on cash return
• +1 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Data Collective (DCVC): US deep-tech venture firm co-founded by Archimedes Managing Director Matthew Ocko — closely comparable stage range and operator-led thesis.
• General Catalyst: Multi-stage US venture firm with an operating/operating-partner focus and seed-to-growth deployment — closely mirrors Archimedes' investment range and value-add orientation.
• Andreessen Horowitz: US-based multi-stage venture and growth firm investing from seed through late stage with a strong operating-partner model — directly comparable to Archimedes' multi-stage, operator-led thesis.
• Founders Fund: US venture and late-stage private equity firm deploying across stages with operator-principal DNA — comparable to Archimedes' venture/PE blend and operator-led positioning.
• Khosla Ventures: Multi-stage US venture investor from seed to growth, with strong operator-founder backing — directly comparable stage coverage and value-add orientation.
• Sequoia Capital: Premier multi-stage US venture firm covering seed through pre-IPO and later stages with operating partner support — directly overlaps Archimedes' stage range and operating-expertise model.
• Insight Partners: US multi-stage firm with strong growth-stage and pre-IPO focus plus operating-value-add — comparable on late-stage PE and operating-execution model.
• Bessemer Venture Partners: Long-tenured US multi-stage venture firm investing from seed through growth with deep operating resources — directly comparable on stage coverage and longevity.
• Norwest Venture Partners: Multi-stage US venture and growth equity firm with operating-partner support — directly comparable on stage coverage and value-add orientation.
• TPG Capital: Large multi-strategy US private equity and growth investor including venture and late-stage — comparable PE/venture blend and stage breadth.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Archimedes Capital